Bruce Cameron Conway agreed in writing to keep a corporate merger secret, then used that secret to fill fifteen family brokerage accounts with insider-traded stock while every other investor in America had absolutely no idea what was coming.

This is how wealth compounds in the shadows. A wealthy Dallas investor gets a call from his investment adviser about a hot private deal. He signs a confidentiality agreement. He even emails back confirming he’ll stay quiet. Then he opens fifteen accounts, spreads insider-traded shares across his own name, his wife’s name, his daughter’s name, his son’s name, and a cluster of family trusts, and waits for the news to drop.

The news dropped on August 24, 2020. Cancer Genetics, Inc. (CGIX) announced its merger with the unnamed private biotech company. The stock went from $2.90 to $6.25 in a single trading day, with intraday highs hitting $10.39 per share. Conway had been buying at an average of $2.99 per share. The public bought in at the open, chasing a headline they just read. Conway had known for over a month.

The Securities and Exchange Commission filed its complaint against Conway on August 7, 2025, nearly five years after the trades. The SEC is seeking full disgorgement of profits, civil monetary penalties, and a permanent injunction barring Conway from pulling this kind of scheme again.

48,250 Shares. 15 Accounts. One Family.

The Non-Financial Ledger

He Agreed to Keep the Secret. He Bought Anyway.

On July 15, 2020, an Investment Adviser employee sent Conway a confidentiality agreement. The agreement was explicit: Conway was required to not share, forward, or otherwise act upon the nonpublic information about the merger. Conway emailed back. He confirmed, in writing, that he agreed to keep it confidential. His printer was allegedly out of ink, so he never returned a signed hard copy. But he typed out the words: “I am emailing a response to agree to keep this confidential.” Then, seven days later, Conway was buying CGIX shares.

That detail matters because it demolishes any argument about confusion or ignorance. Conway understood exactly what he was holding. The SEC documents state plainly that “Conway was aware of the sensitive nature of the material nonpublic information relating to securities issuers and the duties and obligations attendant upon receiving such information, which were explained in the confidentiality agreement he was sent.” This was spelled out for him. He agreed. He acted anyway.

The Investment Adviser Employee 1 eventually found out that Conway had bought CGIX stock after receiving the confidential merger information. According to the SEC complaint, that employee “admonished Conway after learning that Conway had bought CGIX.” Being admonished by the very person who brought you the deal, the person whose own name and firm were potentially on the line, is a serious moment. Conway kept trading after that. Between July 22 and August 21, 2020, he continued purchasing shares across multiple accounts, right up until two days before the public announcement.

He Took the Fifth Rather Than Explain Himself

During the SEC’s investigation, Conway was asked directly about his purchase of CGIX shares. He invoked his Fifth Amendment right against self-incrimination and refused to answer. That is a constitutionally protected right, and we are not here to argue otherwise. But the public record also shows that on March 18, 2022, during a call with an SEC staff attorney, Conway admitted that he knew the identity of the merger target before he bought CGIX shares. He confirmed the core of the allegation himself. Then, when asked to elaborate under the formal investigation, he went silent.

The money Conway made, $160,936.22 (roughly what a teacher in Texas earns over three full years of work), came out of the market ecosystem that regular people also participate in. Every dollar of illegal profit extracted through information asymmetry represents a trade that went the wrong way for someone on the other side of it, someone who did not have a private investment adviser hand-delivering merger intelligence to their inbox with a note saying “I would love to see you invest with us.”

Legal Receipts

The Exact Words From the Complaint

“[Private Biotech Company] has been negotiating to merge into a micro-cap biotech (‘Pubco’) wherein the [Private Biotech Company] shareholders will own 79.9% of the company and control the board of directors.”

Investment Adviser Employee 1, email to Conway, July 15, 2020 — as quoted in SEC Complaint, paragraph 13

“I am emailing a response to agree to keep this confidential.”

Bruce Cameron Conway, written email response to confidentiality agreement, July 15, 2020 — as quoted in SEC Complaint, paragraph 15

“Conway was aware of the sensitive nature of the material nonpublic information relating to securities issuers and the duties and obligations attendant upon receiving such information, which were explained in the confidentiality agreement he was sent.”

SEC Complaint, paragraph 16

“Conway purchased CGIX stock on the basis of material, nonpublic information about the CGIX-Private Biotech Company merger. Conway knew, consciously avoided knowing, or was severely reckless in not knowing that the information was material and nonpublic and used that information in the purchase of CGIX stock, which was a substantial factor in his decision to purchase those securities.”

SEC Complaint, paragraph 32

“Conway breached a duty of trust and confidence by trading on the basis of the information and, in so doing, Conway acted with an intent to deceive or defraud.”

SEC Complaint, paragraph 33

The Moment the Secret Became Public

Societal Impact Mapping

Economic Inequality: A Two-Tier Market, By Design

The mechanics of this case illustrate a dynamic that every retail investor should understand: the stock market is presented as an equal playing field, but access to deal-making information flows through private channels that most people will never touch. Conway received this opportunity because he had an investment advisory relationship, signed in 2017, with a Texas-based firm that was plugged into private biotech deal flow. That relationship was the gateway. Regular people do not have those relationships.

Conway’s average purchase price was $2.99 per share. He bought 48,250 shares. The public announcement pushed the closing price to $6.25, with an intraday spike to $10.39. Anyone who bought CGIX shares on August 24, 2020, chasing the news, paid more than double what Conway paid in the weeks prior. The people without insider knowledge funded the exit of the people who had it.

The $160,936.22 ($160,000, roughly three years of median household income for an American family) Conway pocketed did not materialize from thin air. It transferred from the broader market to his family’s fifteen accounts because he had access to information that the market had not yet priced in. That is the definition of extraction. Wealth flowing upward, not through labor or risk, but through privileged access to secrets.

The Systemic Problem Behind One Wealthy Dallas Investor

Conway’s case is a single data point in a much larger pattern. The SEC brought this case, which means the enforcement apparatus worked here. But for every case the SEC files, there are trades made on whispered information that never get caught, accounts that never get traced, deals where the IP address data is never pulled. The Conway case is notable partly because the IP log connected his computer directly to his wife’s, daughter’s, and son’s trading accounts during the exact same window. That kind of digital fingerprint is what made the paper trail undeniable.

The case also reveals how wealth insulates itself during the investigation phase. Conway entered a tolling agreement with the SEC that paused the statute of limitations until September 30, 2025. The complaint was finally filed on August 7, 2025, five years after the trades. The legal machinery grinds slowly. For five years, the profits sat.

The “Cost of a Life” Metric

What Now?

Who Is Being Watched

Bruce Cameron Conway, 74, Dallas County, Texas, is the named defendant. The SEC is pursuing disgorgement of all profits plus prejudgment interest, civil monetary penalties, and a permanent injunction.

The following regulatory bodies have jurisdiction over cases like this and are worth pressuring for faster, more aggressive enforcement:

• SEC (Securities and Exchange Commission): Primary enforcement authority. Filed this complaint. Track their enforcement actions at sec.gov/litigation.
• DOJ (Department of Justice): Can bring parallel criminal charges in insider trading cases. Civil SEC action does not preclude criminal prosecution.
• FINRA (Financial Industry Regulatory Authority): Regulates broker-dealers and investment advisers. The unnamed Investment Adviser in this case operates in Texas and may fall under FINRA oversight.
• Your Congressional Representative: Push for stronger whistleblower protections and faster SEC enforcement timelines. A five-year gap between trades and complaint is too long.

What You Can Do Right Now

The SEC has a whistleblower program that pays 10% to 30% of sanctions collected when a tip leads to a successful enforcement action over $1 million. If you work in finance, investment advising, or corporate deal-making and you have witnessed trades like these, you can report anonymously at sec.gov/whistleblower. Beyond individual action, support organizations fighting for market transparency and financial accountability, including Better Markets, Public Citizen’s financial reform work, and local mutual aid networks that help families build wealth outside of systems rigged against them. The stock market will stay rigged as long as the only people who know the rules are the ones writing them in private.